2022 TESTING TRIAL Effect of oral Methylprednisolone on clinical outcomes in patients with IgA nephropathy Multicenter, investigator-initiated, double-blind, randomized clinical trial Objective: To evaluate the efficacy and safety of corticosteroids in patients with IgA nephropathy at risk of progression as compared to placebo 262 (1) IgA nephropathy proven on renal biopsy (2) Proteinuria:2 1.0g/day (3) […]